Haleon plc (HLN)
NYSE: HLN · Real-Time Price · USD
9.52
+0.03 (0.26%)
Apr 28, 2026, 12:07 PM EDT - Market open
Haleon Market Cap
Haleon has a market cap or net worth of $42.24 billion as of April 28, 2026. Its market cap has decreased by -4.26% in one year.
Market Cap
42.24B
Enterprise Value
52.18B
1-Year Change
-4.26%
Ranking
Category
Stock Price
$9.52
Market Cap Chart
Since July 18, 2022, Haleon's market cap has increased from $34.14B to $42.24B, an increase of 23.70%. That is a compound annual growth rate of 5.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 42.24B | -5.99% |
| Dec 31, 2025 | 44.93B | 5.03% |
| Dec 31, 2024 | 42.77B | 13.06% |
| Dec 29, 2023 | 37.83B | 3.87% |
| Dec 30, 2022 | 36.42B | 6.67% |
| Jul 18, 2022 | 34.14B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Takeda Pharmaceutical Company | 52.84B |
| Zoetis | 49.15B |
| Teva Pharmaceutical Industries | 35.68B |
| United Therapeutics | 24.86B |
| Viatris | 16.99B |
| Regencell Bioscience Holdings | 13.59B |
| Neurocrine Biosciences | 12.84B |
| Dr. Reddy's Laboratories | 11.63B |